As your dose increases and your body adjusts, weight loss tends to accelerate, especially between weeks 8 to 12
Semaglutide is a prescription medication originally developed to manage type 2 diabetes, now FDA-approved for medical weight loss under brand names like Wegovy and Ozempic
That naming riddle seems solved, but the real complication concerns systems and behavior, and the next section unpacks how brand, generic, and approval differences actually influence access, dosing, and clinical choices
Symptoms are usually temporary and can often be managed with hydration, small dietary changes, and short-term medication if needed
If your medication regimen has changed since your preoperative evaluation, inform your anesthesiologist immediatelythis allows them to implement appropriate safety measures based on current information
The results reported that HbA1c decreased in a dose-dependent manner with doses of 0.2-1.6 mg of semaglutide causing a significant decrease in HbA1c levels, in comparison to the placebo group